The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Jump to: Company in focus,
Offsprings
Parent entities and officers
2
- 1
Hnoosh, Ahmed
Management Consultant born in January 1980Individual (1 offspring)Officer2016-08-18 ~ nowOF - Director → CIF 0Mr Ahmed Hnoosh
Born in January 1980Individual (1 offspring)Person with significant control2016-08-18 ~ nowPE - Ownership of voting rights - 75% or more → CIF 0PE - Ownership of shares – 75% or more → CIF 02016-08-18 ~ 2020-01-10PE - Ownership of shares – 75% or more → CIF 0PE - Ownership of voting rights - 75% or more → CIF 0 - 2
Nimish Chandrakant Patel
Individual (1327 offsprings)Insolvency2021-09-28 ~ nowIP - (Case 1) practitioner → CIF 0
Company in focus
ALPHA PHARMA CONSULTING LTD
Period: 2016-08-18 ~ 2022-07-08
Company number: 10336314
Registered name
ALPHA PHARMA CONSULTING LTD - Dissolved
Standard Industrial Classification
70229 - Management Consultancy Activities Other Than Financial Management
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Turnover/Revenue
167,081 GBP2020-04-01 ~ 2021-03-31
143,573 GBP2019-04-01 ~ 2020-03-31
Cost of Sales
0 GBP2020-04-01 ~ 2021-03-31
0 GBP2019-04-01 ~ 2020-03-31
Gross Profit/Loss
167,081 GBP2020-04-01 ~ 2021-03-31
143,573 GBP2019-04-01 ~ 2020-03-31
Distribution Costs
0 GBP2020-04-01 ~ 2021-03-31
0 GBP2019-04-01 ~ 2020-03-31
Administrative Expenses
-14,602 GBP2020-04-01 ~ 2021-03-31
-24,426 GBP2019-04-01 ~ 2020-03-31
Other operating income
0 GBP2020-04-01 ~ 2021-03-31
0 GBP2019-04-01 ~ 2020-03-31
Operating Profit/Loss
152,479 GBP2020-04-01 ~ 2021-03-31
119,147 GBP2019-04-01 ~ 2020-03-31
Other Interest Receivable/Similar Income (Finance Income)
0 GBP2020-04-01 ~ 2021-03-31
4 GBP2019-04-01 ~ 2020-03-31
Interest Payable/Similar Charges (Finance Costs)
0 GBP2020-04-01 ~ 2021-03-31
0 GBP2019-04-01 ~ 2020-03-31
Profit/Loss on Ordinary Activities Before Tax
152,479 GBP2020-04-01 ~ 2021-03-31
119,151 GBP2019-04-01 ~ 2020-03-31
Tax/Tax Credit on Profit or Loss on Ordinary Activities
-29,125 GBP2020-04-01 ~ 2021-03-31
-22,793 GBP2019-04-01 ~ 2020-03-31
Called-up share capital not yet paid and not classified as a current asset
0 GBP2021-03-31
0 GBP2020-03-31
Intangible Assets
0 GBP2021-03-31
0 GBP2020-03-31
Property, Plant & Equipment
1,622 GBP2021-03-31
2,433 GBP2020-03-31
Fixed Assets - Investments
0 GBP2021-03-31
0 GBP2020-03-31
Fixed Assets
1,622 GBP2021-03-31
2,433 GBP2020-03-31
Total Inventories
0 GBP2021-03-31
0 GBP2020-03-31
Debtors
17,550 GBP2021-03-31
750 GBP2020-03-31
Cash at bank and in hand
329,219 GBP2021-03-31
252,147 GBP2020-03-31
Current assets - Investments
0 GBP2021-03-31
0 GBP2020-03-31
Current Assets
346,769 GBP2021-03-31
252,897 GBP2020-03-31
Net Current Assets/Liabilities
304,835 GBP2021-03-31
221,670 GBP2020-03-31
Total Assets Less Current Liabilities
306,457 GBP2021-03-31
224,103 GBP2020-03-31
Net Assets/Liabilities
306,457 GBP2021-03-31
224,103 GBP2020-03-31
Equity
Called up share capital
10 GBP2021-03-31
10 GBP2020-03-31
Share premium
0 GBP2021-03-31
0 GBP2020-03-31
Retained earnings (accumulated losses)
306,447 GBP2021-03-31
224,093 GBP2020-03-31
Equity
306,457 GBP2021-03-31
224,103 GBP2020-03-31
Average Number of Employees
12020-04-01 ~ 2021-03-31
12019-04-01 ~ 2020-03-31
Property, Plant & Equipment - Gross Cost
Office equipment
3,604 GBP2021-03-31
3,604 GBP2020-03-31
Property, Plant & Equipment - Gross Cost
3,604 GBP2021-03-31
3,604 GBP2020-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
1,982 GBP2021-03-31
1,171 GBP2020-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
1,982 GBP2021-03-31
1,171 GBP2020-03-31
Property, Plant & Equipment - Other increase or decrease in the depreciation or impairment
811 GBP2020-04-01 ~ 2021-03-31
Property, Plant & Equipment
Office equipment
1,622 GBP2021-03-31
2,433 GBP2020-03-31
Trade Debtors/Trade Receivables
17,550 GBP2021-03-31
0 GBP2020-03-31
Prepayments/Accrued Income
0 GBP2021-03-31
750 GBP2020-03-31
Other Debtors
0 GBP2021-03-31
0 GBP2020-03-31
Trade Creditors/Trade Payables
Amounts falling due within one year
75 GBP2021-03-31
75 GBP2020-03-31
Taxation/Social Security Payable
Amounts falling due within one year
39,151 GBP2021-03-31
27,999 GBP2020-03-31
Accrued Liabilities/Deferred Income
Amounts falling due within one year
970 GBP2021-03-31
0 GBP2020-03-31
Other Creditors
Amounts falling due within one year
1,738 GBP2021-03-31
3,153 GBP2020-03-31
- Registered number 10336314
ALPHA PHARMA CONSULTING LTD
Info58 Hugh Street, London SW1V 4ERPRIVATE LIMITED COMPANY incorporated on 2016-08-18 and dissolved on 2022-07-08 (5 years 10 months). The status of the company number is Dissolved.CIF 0
Offspring entities and appointments
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 22 April 2026 and
licensed under the Open Government Licence v3.0.